3 Day Pharmacovigilance for Drug Safety, Regulatory Affairs

Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training...

Related Keywords

Ashbourne ,Meath ,Ireland ,Japan ,United States ,Dublin ,Graeme Ladds ,Pharsafer Associates Ltd ,Ashbourne Pharmaceuticals ,Development Of The Dictionary ,Regulatory Affairs ,Head Of Global Pharmacovigilance At Shire Pharmaceuticals ,Company Products ,Drug Safety ,Knowledge Training ,Medical Device ,Should Attend ,Topics Covered ,Record Form Design ,Individual Serious Adverse Event ,Post Marketing Drug ,Marketing Safety ,Clinical Safety ,Clinical Animal ,Quality Safety ,Blinded Study ,Comparator Products ,Blinded Study Safety ,Medical Devices ,Capturing Pregnancy ,Data Forms ,Liver Disease ,Hepatic Adverse Drug ,Renal Adverse Drug ,Immunological Adverse Drug ,Cardiovascular Disease ,Adverse Drug ,Medical Information ,Global Pharmacovigilance ,Pharsafer Associates ,Research And Markets ,Adverse Drug Reaction ,Drug Discovery ,Pharmacovigilance ,Placebo ,Pre Clinical ,Training Course ,